C-peptide and Na+,K+-ATPase in Diabetes
Author Information
Author(s): P. Vague, T. C. Coste, M. F. Jannot, D. Raccah, M. Tsimaratos
Primary Institution: Departement de Nutrition-Endocrinologie-Maladies Metaboliques, Marseille, France
Hypothesis
The study investigates the relationship between C-peptide levels and Na+,K+-ATPase activity in diabetic patients.
Conclusion
C-peptide administration can restore Na+,K+-ATPase activity in diabetic patients, which may help prevent complications associated with diabetes.
Supporting Evidence
- C-peptide infusion restores Na+,K+-ATPase activity in type 1 diabetic patients.
- Low Na+,K+-ATPase activity is associated with diabetic complications.
- C-peptide levels correlate with Na+,K+-ATPase activity in type 2 diabetic patients.
- Short-term C-peptide infusion improves erythrocyte Na+,K+-ATPase activity.
- Diabetic patients with low C-peptide levels show decreased enzyme activity.
Takeaway
C-peptide helps a special enzyme work better in people with diabetes, which can make them feel healthier.
Methodology
The study involved both in vivo and in vitro experiments to assess the effects of C-peptide on Na+,K+-ATPase activity in diabetic patients and animal models.
Potential Biases
Potential biases may arise from the selection of participants and the methods used to measure enzyme activity.
Limitations
The study primarily focuses on specific populations and may not be generalizable to all diabetic patients.
Participant Demographics
The study includes type 1 and type 2 diabetic patients, with a focus on those with varying levels of C-peptide.
Statistical Information
P-Value
0.002
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website